FDA approves revised medication guide for Coumadin

Share this content:
The FDA has approved a revised medication guide and labeling for Bristol-Myers Squibb's blood thinner Coumadin (warfarin sodium) to more prominently emphasize a warning about the risk of major or fatal bleeding.
Share this content:
Scroll down to see the next article